Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Review ArticleReview Article
Open Access

The use of immune modulating drugs for the treatment of multiple sclerosis

Fahd A. Al-Khamis
Neurosciences Journal January 2016, 21 (1) 4-9; DOI: https://doi.org/10.17712/nsj.2016.1.20150252
Fahd A. Al-Khamis
From the Department of Neurology, Faculty of Medicine, Deanship for Scientific Research, University of Dammam, Dammam, Kingdom of Saudi Arabia
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 21 no. 1 4-9
DOI 
https://doi.org/10.17712/nsj.2016.1.20150252
PubMed 
26818160

Published By 
Neurosciences Journal
Online ISSN 
1658-3183
History 
  • Received April 11, 2015
  • Accepted September 3, 2015
  • Published online November 13, 2020.

Copyright & Usage 
Copyright: © Neurosciences Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

  1. Fahd A. Al-Khamis, MBBS⇑
  1. From the Department of Neurology, Faculty of Medicine, Deanship for Scientific Research, University of Dammam, Dammam, Kingdom of Saudi Arabia
  1. Address correspondence and reprint request to: Dr. Fahd A. Al-Khamis, Department of Neurology, Faculty of Medicine, Deanship for Scientific Research, University of Dammam, Dammam, Kingdom of Saudi Arabia. E-mail: fkhamis{at}uod.edu.sa
View Full Text

Cited By...

  • 9 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Update on Disease-Modifying Therapies for Multiple Sclerosis
    Diana L Vargas, William R Tyor
    Journal of Investigative Medicine 2017 65 5
  • Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
    Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, Karina Torres Pomini, Cristiano Machado Galhardi, Claudia Rucco Penteado Detregiachi, Luíza Santos de Argollo Haber, Domingos Donizeti Roque, Marcelo Dib Bechara, Marcela Vialogo Marques de Castro, Eliana de Souza Bastos Mazuqueli Pereira, Ricardo José Tofano, Iris Jasmin Santos German Borgo, Sandra Maria Barbalho
    Frontiers in Immunology 2024 14
  • Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells
    Janine Schlöder, Carsten Berges, Felix Luessi, Helmut Jonuleit
    International Journal of Molecular Sciences 2017 18 2
  • Inhalation of dimethyl fumarate-encapsulated solid lipid nanoparticles attenuate clinical signs of experimental autoimmune encephalomyelitis and pulmonary inflammatory dysfunction in mice
    Bárbara Fernandes Pinto, Lorena Natasha Brito Ribeiro, Gisela Bevilacqua Rolfsen Ferreira da Silva, Camila Simões Freitas, Lucas Kraemer, Fabrício Marcus Silva Oliveira, Marianna Carvalho Clímaco, Flávio Afonso Gonçalves Mourão, Gabryella Soares Pinheiro dos Santos, Samantha Ribeiro Béla, Isabella Luísa da Silva Gurgel, Fábio de Lima Leite, Anselmo Gomes de Oliveira, Maura Regina Silva da Páscoa Vilela, Onésia Cristina Oliveira-Lima, Frederico Marianetti Soriani, Ricardo Toshio Fujiwara, Alexander Birbrair, Remo Castro Russo, Juliana Carvalho-Tavares
    Clinical Science 2022 136 1
  • TGFβ1 transduction enhances immunomodulatory capacity of neural stem cells in experimental autoimmune encephalomyelitis
    Chong Xie, Xing Li, Xiajun Zhou, Zezhi Li, Yuan Zhang, Li Zhao, Yong Hao, Guang-Xian Zhang, Yangtai Guan
    Brain, Behavior, and Immunity 2018 69
  • Cellular analyses in the monitoring of autoimmune diseases
    Ulrich Sack, Andreas Boldt, Nora Mallouk, Rudolf Gruber, Veit Krenn, Anne-Emmanuelle Berger-Depincé, Karsten Conrad, Attila Tarnok, Claude Lambert, Dirk Reinhold, Stephan Fricke
    Autoimmunity Reviews 2016 15 9
  • Cytokines and Transgenic Matrix in Autoimmune Diseases: Similarities and Differences
    Ludmiła Szewczak, Katarzyna Donskow-Łysoniewska
    Biomedicines 2020 8 12
  • Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model
    Tammie Choi, Bryan Chan, Lisa Grech, Alastair Kwok, Kate Webber, Jennifer Wong, Mike Nguyen, Nathan Bain, Daphne Day, Amelia McCartney, Ruby Hamer, Eva Segelov
    Vaccines 2023 11 2
  • Nano-based approaches for the treatment of neuro-immunological disorders: a special emphasis on multiple sclerosis
    Archna Panghal, S. J. S. Flora
    Discover Nano 2024 19 1
PreviousNext
Back to top

In this issue

Neurosciences Journal: 21 (1)
Neurosciences Journal
Vol. 21, Issue 1
1 Jan 2016
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The use of immune modulating drugs for the treatment of multiple sclerosis
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
The use of immune modulating drugs for the treatment of multiple sclerosis
Fahd A. Al-Khamis
Neurosciences Journal Jan 2016, 21 (1) 4-9; DOI: 10.17712/nsj.2016.1.20150252

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The use of immune modulating drugs for the treatment of multiple sclerosis
Fahd A. Al-Khamis
Neurosciences Journal Jan 2016, 21 (1) 4-9; DOI: 10.17712/nsj.2016.1.20150252
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Structural and functional changes in the hippocampus induced by environmental exposures
  • Tumefactive demyelinating lesions: A literature review of recent findings
  • Epilepsia partialis continua: A review
Show more Review Article

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire